SEC Company Response from BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308) (ONC) — Nov 17, 2016
BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308)
Date: Nov. 17, 2016 · CIK: 0001651308 · Accession: 0001104659-16-157768
AI Filing Summary & Sentiment
Reasoning
Letter
Morgan Stanley & Co. LLC
1585 Broadway
New York, New York 10036
Goldman, Sachs & Co.
200 West Street
New York, New York 10282
Cowen and Company, LLC
599 Lexington Avenue, 27th Floor
New York, NY 10022
November 17, 2016
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Dorrie Yale
Re:
BeiGene, Ltd.
Registration Statement on Form S-1 (File No. 333- 214540)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of BeiGene, Ltd. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on November 17, 2016, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several Underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Goldman, Sachs & Co. 200 West Street New York, New York 10282 Cowen and Company, LLC 599 Lexington Avenue, 27th Floor New York, NY 10022 November 17, 2016 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Dorrie Yale Re: BeiGene, Ltd. Registration Statement on Form S-1 (File No. 333- 214540) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of BeiGene, Ltd. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on November 17, 2016, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several Underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, MORGAN STANLEY & CO. LLC GOLDMAN, SACHS & CO. COWEN AND COMPANY, LLC Acting severally on behalf of themselves and the several Underwriters MORGAN STANLEY & CO. LLC By: /s/ Kathy Bergsteinsson Name: Kathy Bergsteinsson Title: Managing Director GOLDMAN, SACHS & CO. By: /s/ Matt Leavitt Name: Matt Leavitt Title: Managing Director COWEN AND COMPANY, LLC By: /s/ Jason Fenton Name: Jason Fenton Title: Managing Director